F. John. Gennari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
F. John. Gennari has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
John A. Sargent
Orinda CA USA
4 shared publicationsStefano Marano
Department of Information and Electrical Engineering and Applied Mathematics (DIEM), University of Salerno, Fisciano, Italy
3 shared publications- Marco Marano
Hemodialysis Unit, Maria Rosaria Clinic, Pompeii, Naples, Italy
2 shared publications Alan Segal
Department of Medicine, University of Vermont College of Medicine, Burlington, VT
1 shared publicationBruce I. Tranmer
Department of Surgery, Fletcher Allen Health Care, University of Vermont College of Medicine, Burlington, VT
1 shared publicationDesirée De Waal
University of Vermont Medical Center Burlington VT USA
1 shared publication
Latest Publications
- Open Access
- 30 July 2022
- Published by Elsevier in Kidney Medicine
- Vol. 4 (9) , 100523
Replenishing Alkali During Hemodialysis: Physiology-Based Approaches
- 30 July 2022
- Published by Elsevier in Kidney Medicine
- Vol. 4 (9) , 100523
Open AccessReplenishing Alkali During Hemodialysis: Physiology-Based Approaches
- 15 August 2020
- Published by Wiley in Seminars in Dialysis
- Vol. 33 (5) , 402-409
Hemodialysis using a low bicarbonate dialysis bath: Implications for acid‐base homeostasis
The low bath bicarbonate concentration ([]) used by a nephrology group in Japan (25.5 mEq/L), coupled with a bath [acetate] of 8 mEq/L, provided an opportunity to study the acid‐base events occurring during hemodialysis when flux is from the patient to the bath. We used an analytic tool that allows calculation of delivery during hemodialysis and the physiological response to it in 17 Japanese outpatients with an average pre‐dialysis blood [] of 25 mEq/L. Our analysis demonstrates that addition is markedly reduced and that all of it comes from acetate metabolism. The added to the extracellular fluid during treatment (19.5 mEq) was completely consumed by H+ mobilization from body buffers. In contrast to patients dialyzing with higher bath [] values in the US and Europe, organic acid production was suppressed rather than stimulated. Dietary analysis indicates that these patients are in acid balance due to the alkaline nature of their diet. In a larger group of patients using the same bath solution, pre‐dialysis blood [] was lower, 22.2 mEq/L, but still in an acceptable range. Our studies indicate that a low bath [] is well tolerated and can prevent stimulation of organic acid production.
- 15 August 2020
- Published by Wiley in Seminars in Dialysis
- Vol. 33 (5) , 402-409
Hemodialysis using a low bicarbonate dialysis bath: Implications for acid‐base homeostasis
The low bath bicarbonate concentration ([]) used by a nephrology group in Japan (25.5 mEq/L), coupled with a bath [acetate] of 8 mEq/L, provided an opportunity to study the acid‐base events occurring during hemodialysis when flux is from the patient to the bath. We used an analytic tool that allows calculation of delivery during hemodialysis and the physiological response to it in 17 Japanese outpatients with an average pre‐dialysis blood [] of 25 mEq/L. Our analysis demonstrates that addition is markedly reduced and that all of it comes from acetate metabolism. The added to the extracellular fluid during treatment (19.5 mEq) was completely consumed by H+ mobilization from body buffers. In contrast to patients dialyzing with higher bath [] values in the US and Europe, organic acid production was suppressed rather than stimulated. Dietary analysis indicates that these patients are in acid balance due to the alkaline nature of their diet. In a larger group of patients using the same bath solution, pre‐dialysis blood [] was lower, 22.2 mEq/L, but still in an acceptable range. Our studies indicate that a low bath [] is well tolerated and can prevent stimulation of organic acid production.
- 21 April 2019
- Published by Wiley in Seminars in Dialysis
- Vol. 32 (3) , 274-275
Acetate metabolism, organic acid production, and the independent effects of bicarbonate and acetate as alkalinizing agents in dialysis bath solutions
- 21 April 2019
- Published by Wiley in Seminars in Dialysis
- Vol. 32 (3) , 274-275
Acetate metabolism, organic acid production, and the independent effects of bicarbonate and acetate as alkalinizing agents in dialysis bath solutions
- 3 April 2019
- Published by Wiley in Seminars in Dialysis
- Vol. 32 (3) , 248-254
Changing dialysate composition to optimize acid‐base therapy
In response to rapid alkali delivery during hemodialysis, hydrogen ions (H+) are mobilized from body buffers and from stimulation of organic acid production in amounts sufficient to convert most of the delivered bicarbonate to CO2 and water. Release of H+ from nonbicarbonate buffers serves to back‐titrate them to a more alkaline state, readying them to buffer acids that accumulate in the interval between treatments. By contrast, stimulation of organic acid production only serves to remove added bicarbonate (HCO3−) from the body; the organic anions produced by this process are lost into the dialysate, irreversibly acidifying the patient as well as diverting metabolic activity from normal homeostasis. We have developed an analytic tool to quantify these acid‐base events, which has shown that almost two‐thirds of the H+ mobilized during hemodialysis comes from organic acid production when bath bicarbonate concentration ([HCO3−]) is 32 mEq/L or higher. Using data from the hemodialysis patients we studied with our analytical model, we have simulated the effect of changing bath solute on estimated organic acid production. Our simulations demonstrate that reducing bath [HCO3−] should decrease organic acid production, a change we propose as beneficial to the patient. They also highlight the differential effects of variations in bath acetate concentration, as compared to [HCO3−], on the amount and rate of alkali delivery. Our results suggest that transferring HCO3− delivery from direct influx to acetate influx and metabolism provides a more stable and predictable rate of HCO3− addition to the patient receiving bicarbonate‐based hemodialysis. Our simulations provide the groundwork for the clinical studies needed to verify these conclusions.
- 3 April 2019
- Published by Wiley in Seminars in Dialysis
- Vol. 32 (3) , 248-254
Changing dialysate composition to optimize acid‐base therapy
In response to rapid alkali delivery during hemodialysis, hydrogen ions (H+) are mobilized from body buffers and from stimulation of organic acid production in amounts sufficient to convert most of the delivered bicarbonate to CO2 and water. Release of H+ from nonbicarbonate buffers serves to back‐titrate them to a more alkaline state, readying them to buffer acids that accumulate in the interval between treatments. By contrast, stimulation of organic acid production only serves to remove added bicarbonate (HCO3−) from the body; the organic anions produced by this process are lost into the dialysate, irreversibly acidifying the patient as well as diverting metabolic activity from normal homeostasis. We have developed an analytic tool to quantify these acid‐base events, which has shown that almost two‐thirds of the H+ mobilized during hemodialysis comes from organic acid production when bath bicarbonate concentration ([HCO3−]) is 32 mEq/L or higher. Using data from the hemodialysis patients we studied with our analytical model, we have simulated the effect of changing bath solute on estimated organic acid production. Our simulations demonstrate that reducing bath [HCO3−] should decrease organic acid production, a change we propose as beneficial to the patient. They also highlight the differential effects of variations in bath acetate concentration, as compared to [HCO3−], on the amount and rate of alkali delivery. Our results suggest that transferring HCO3− delivery from direct influx to acetate influx and metabolism provides a more stable and predictable rate of HCO3− addition to the patient receiving bicarbonate‐based hemodialysis. Our simulations provide the groundwork for the clinical studies needed to verify these conclusions.
- 29 May 2018
- Published by Wiley in Seminars in Dialysis
- Vol. 31 (5) , 468-478
Acid‐base homeostasis during hemodialysis: New insights into the mystery of bicarbonate disappearance during treatment
In patients receiving hemodialysis, it has long been recognized that much more bicarbonate is delivered during treatment than ultimately appears in the blood. To gain insight into this mystery, we developed a model that allows a quantitative analysis of the patient's response to rapid alkalinization during hemodialysis. Our model is unique in that it is based on the distribution of bicarbonate in the extracellular fluid and assesses its removal from this compartment by mobilization of protons (H+) from buffers and other sources. The model was used to analyze the pattern of rise in blood bicarbonate concentration ([HCO3−]), calculated from measurements of pH and PCO2, in patients receiving standard bicarbonate hemodialysis. Model analysis demonstrated two striking findings: (1) 35% of the bicarbonate added during hemodialysis was due to influx and metabolism of acetate, despite its low concentration in the bath solution, because of the rapidly collapsing gradient for bicarbonate influx. (2) Almost 90% of the bicarbonate delivered to the patients was neutralized by H+ generation. Virtually all the new H+ came from intracellular sources and included both buffering and organic acid production. The small amount of added bicarbonate retained in the extracellular fluid increased blood [HCO3−], on average, by 6 mEq/L in our patients. Almost all this rise occurred during the first 2 hours. Thereafter, blood [HCO3−] changed minimally and always remained less than bath [HCO3−]. This lack of equilibrium was due to the continued production of organic acid. Release of H+ from buffers is a reversible physiological response, restoring body alkali stores. By contrast, organic acid production is an irreversible process during hemodialysis and is metabolically inefficient and potentially catabolic. Our analysis underscores the need to develop new approaches for alkali repletion during hemodialysis that minimize organic acid production.
- 29 May 2018
- Published by Wiley in Seminars in Dialysis
- Vol. 31 (5) , 468-478
Acid‐base homeostasis during hemodialysis: New insights into the mystery of bicarbonate disappearance during treatment
In patients receiving hemodialysis, it has long been recognized that much more bicarbonate is delivered during treatment than ultimately appears in the blood. To gain insight into this mystery, we developed a model that allows a quantitative analysis of the patient's response to rapid alkalinization during hemodialysis. Our model is unique in that it is based on the distribution of bicarbonate in the extracellular fluid and assesses its removal from this compartment by mobilization of protons (H+) from buffers and other sources. The model was used to analyze the pattern of rise in blood bicarbonate concentration ([HCO3−]), calculated from measurements of pH and PCO2, in patients receiving standard bicarbonate hemodialysis. Model analysis demonstrated two striking findings: (1) 35% of the bicarbonate added during hemodialysis was due to influx and metabolism of acetate, despite its low concentration in the bath solution, because of the rapidly collapsing gradient for bicarbonate influx. (2) Almost 90% of the bicarbonate delivered to the patients was neutralized by H+ generation. Virtually all the new H+ came from intracellular sources and included both buffering and organic acid production. The small amount of added bicarbonate retained in the extracellular fluid increased blood [HCO3−], on average, by 6 mEq/L in our patients. Almost all this rise occurred during the first 2 hours. Thereafter, blood [HCO3−] changed minimally and always remained less than bath [HCO3−]. This lack of equilibrium was due to the continued production of organic acid. Release of H+ from buffers is a reversible physiological response, restoring body alkali stores. By contrast, organic acid production is an irreversible process during hemodialysis and is metabolically inefficient and potentially catabolic. Our analysis underscores the need to develop new approaches for alkali repletion during hemodialysis that minimize organic acid production.
- 1 March 2018
- Published by Wiley in Seminars in Dialysis
- Vol. 31 (4) , 382-387
Acid‐base assessment of patients receiving hemodialysis. What are our management goals?
Acid‐base assessment of patients receiving conventional hemodialysis (HD) has been based solely on predialysis serum [total CO2], and treatment is currently driven by the KDOQI guideline from 2000. This guideline was directed solely at minimizing metabolic acidosis and thereby improving bone and muscle metabolism. In 2000, no data were available to assess the effects of acid‐base status on morbidity and mortality. Since then, new data have emerged from several large cohort studies about the association between variations in predialysis serum [total CO2], as well as blood pH, and morbidity and mortality risk. These studies have shown increased risk not only with very low predialysis [total CO2] values, but also with predialysis alkaline pH and very high predialysis serum [total CO2] values. At present, our major concern is not for patients with metabolic acidosis, but rather for the growing numbers of patients with metabolic alkalosis. This review discusses the controversies around assessing and treating acid‐base status in HD patients, and recommends a practical approach based on the results of these recent studies. The new approach provides recommendations for patients both with very low and very high predialysis serum [total CO2] values.
- 1 March 2018
- Published by Wiley in Seminars in Dialysis
- Vol. 31 (4) , 382-387
Acid‐base assessment of patients receiving hemodialysis. What are our management goals?
Acid‐base assessment of patients receiving conventional hemodialysis (HD) has been based solely on predialysis serum [total CO2], and treatment is currently driven by the KDOQI guideline from 2000. This guideline was directed solely at minimizing metabolic acidosis and thereby improving bone and muscle metabolism. In 2000, no data were available to assess the effects of acid‐base status on morbidity and mortality. Since then, new data have emerged from several large cohort studies about the association between variations in predialysis serum [total CO2], as well as blood pH, and morbidity and mortality risk. These studies have shown increased risk not only with very low predialysis [total CO2] values, but also with predialysis alkaline pH and very high predialysis serum [total CO2] values. At present, our major concern is not for patients with metabolic acidosis, but rather for the growing numbers of patients with metabolic alkalosis. This review discusses the controversies around assessing and treating acid‐base status in HD patients, and recommends a practical approach based on the results of these recent studies. The new approach provides recommendations for patients both with very low and very high predialysis serum [total CO2] values.
- 1 September 2015
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 66 (3) , 383-385
Acid-Base Status and Mortality Risk in Hemodialysis Patients
- 1 September 2015
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 66 (3) , 383-385
Acid-Base Status and Mortality Risk in Hemodialysis Patients
- 1 July 2014
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 64 (1) , 151-155
Approach to the Hemodialysis Patient With an Abnormal Serum Bicarbonate Concentration
- 1 July 2014
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 64 (1) , 151-155
Approach to the Hemodialysis Patient With an Abnormal Serum Bicarbonate Concentration
- 1 March 2014
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 63 (3) , 530-535
Severe Hypokalemia in a Patient With Subarachnoid Hemorrhage
- 1 March 2014
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 63 (3) , 530-535
Severe Hypokalemia in a Patient With Subarachnoid Hemorrhage
- 1 July 2013
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 62 (1) , 20-2
Intravenous fluid therapy: saline versus mixed electrolyte and organic anion solutions.
- 1 July 2013
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 62 (1) , 20-2
Intravenous fluid therapy: saline versus mixed electrolyte and organic anion solutions.